The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective
Open accessAbstract
AIMS: Hereditary transthyretin (TTR)-related amyloidosis (ATTR) is mainly considered a neurologic disease. We assessed the phenotypic and genotypic spectra of ATTR in a Caucasian area and evaluated the prevalence, genetic background, and disease profile of cases with an exclusively cardiac phenotype, highlighting possible hints for the differential diagnosis with hypertrophic cardiomyopathy (HCM) and senile systemic amyloidosis (SSA). METHODS AND RESULTS: In this Italian multicentre study, 186 patients with ATTR were characterized at presentation. Thirty patients with SSA and 30 age-gender-matched HCM patients were used for comparison. Phenotype was classified as exclusively cardiac (n = 31, 17%), exclusively neurologic (n = 46, 25%), and mixed cardiac/neurologic (n = 109, 58%). Among the eight different mutations responsible for an exclusively cardiac phenotype, Ile68Leu was the most frequent. Five patients with an exclusively cardiac phenotype developed mild abnormalities at neurological examination, but no symptoms during a 36-month follow-up (range: 14-50). Exclusively cardiac phenotype was characterized by male gender, age >65 years, heart failure symptoms, symmetric left ventricular (LV) 'hypertrophy', and moderately depressed LV ejection fraction. This profile was similar to SSA, but relatively distinct from HCM. Compared with patients with a mixed phenotype, patients with an exclusively cardiac phenotype showed a more pronounced cardiac involvement on both echocardiogram and electrocardiogram (ECG). CONCLUSION: A clinically relevant subset of Caucasian ATTR patients present with an exclusively cardiac phenotype, mimicking HCM or SSA. Echocardiographic and ECG findings are useful to differentiate ATTR from HCM but not from SSA. The role of liver transplantation in these patients should be reconsidered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,229
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelista, A. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.11.023 · Cited by 4,367
Recommendations for the evaluation of left ventricular diastolic function by echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelisa, A. (2008) · European Journal of Echocardiography · doi:10.1093/ejechocard/jep007 · Cited by 3,351 · cited 1×
“Left anterior hemiblock, n (%) 12 (39) 7 (23) 6 (20) 0.”
Prevalence of Carpal Tunnel Syndrome in a General Population
Atroshi, I. (1999) · JAMA · doi:10.1001/jama.282.2.153 · Cited by 2,042
Gertz, M. A., Comenzo, R., Falk, R. H., Fermand, J. P., Hazenberg, B. P., Hawkins, P. N., Merlini, G., Moreau, P., Ronco, P., Sanchorawala, V., et al. (2005) · American Journal of Hematology · doi:10.1002/ajh.20381 · Cited by 1,428
Self-citationSystemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types
Rapezzi, C., Merlini, G., Quarta, C. C., Riva, L., Longhi, S., Leone, O., Salvi, F., Ciliberti, P., Pastorelli, F., Biagini, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.843334 · Cited by 774
Self-citationCommittee Members, Cheitlin, M. D., Armstrong, W. F., Aurigemma, G. P., Beller, G. A., Bierman, F. Z., Davis, J. L., Douglas, P. S., Faxon, D. P., Gillam, L. D., et al. (2003) · Circulation · doi:10.1161/01.cir.0000073597.57414.a9 · Cited by 745
Fibril in senile systemic amyloidosis is derived from normal transthyretin.
Westermark, P., Sletten, K., Johansson, B., & Cornwell, G. G. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2843 · Cited by 696
Breathnach, S. M. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)70001-8 · Cited by 615
Variant-Sequence Transthyretin (Isoleucine 122) in Late-Onset Cardiac Amyloidosis in Black Americans
Jacobson, D. R., Pastore, R. D., Yaghoubian, R., Kane, I., Gallo, G., Buck, F. S., & Buxbaum, J. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702133360703 · Cited by 554
The Biological and Chemical Basis for Tissue-Selective Amyloid Disease
Sekijima, Y., Wiseman, R. L., Matteson, J., Hammarström, P., Miller, S. R., Sawkar, A. R., Balch, W. E., & Kelly, J. W. (2005) · Cell · doi:10.1016/j.cell.2005.01.018 · Cited by 488
The molecular biology and clinical features of amyloid neuropathy
Benson, M. D., & Kincaid, J. C. (2007) · Muscle & Nerve · doi:10.1002/mus.20821 · Cited by 447
Transthyretin-Related Familial Amyloidotic Polyneuropathy
Ando, Y., Nakamura, M., & Araki, S. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1057 · Cited by 416
Transthyretin-related amyloidoses and the heart: a clinical overview
Rapezzi, C., Quarta, C. C., Riva, L., Longhi, S., Gallelli, I., Lorenzini, M., Ciliberti, P., Biagini, E., Salvi, F., & Branzi, A. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.67 · Cited by 350
Self-citationNoninvasive diagnosis of biopsy-proven cardiac amyloidosis
Rahman, J. E., Helou, E. F., Gelzer-Bell, R., Thompson, R. E., Kuo, C., Rodriguez, E. R., Hare, J. M., Baughman, K. L., & Kasper, E. K. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.043 · Cited by 334
Herlenius, G., Wilczek, H. E., Larsson, M., & Ericzon, B.-G. (2004) · Transplantation · doi:10.1097/01.tp.0000092307.98347.cb · Cited by 275
Sekijima, Y., Dendle, M. A., & Kelly, J. W. (2006) · Amyloid · doi:10.1080/13506120600960882 · Cited by 268
Falk, R. H., & Dubrey, S. W. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.11.007 · Cited by 244
Chou's electrocardiography in clinical practice : adult and pediatric
Surawicz, B., Chou, T.-C., & Knilans, T. K. (2001) · Cited by 209
Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis
Ihse, E., Ybo, A., Suhr, O., Lindqvist, P., Backman, C., & Westermark, P. (2008) · The Journal of Pathology · doi:10.1002/path.2411 · Cited by 209
Sattianayagam, P. T., Hahn, A. F., Whelan, C. J., Gibbs, S. D. J., Pinney, J. H., Stangou, A. J., Rowczenio, D., Pflugfelder, P. W., Fox, Z., Lachmann, H. J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr383 · Cited by 196
PROGRESSION OF VENTRICULAR WALL THICKENING AFTER LIVER TRANSPLANTATION FOR FAMILIAL AMYLOIDOSIS1
Dubrey, S. W., Davidoff, R., Skinner, M., Bergethon, P., Lewis, D., & Falk, R. H. (1997) · Transplantation · doi:10.1097/00007890-199707150-00014 · Cited by 186
Infiltrative Cardiovascular Diseases
Seward, J. B., & Casaclang-Verzosa, G. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.040 · Cited by 174
Connors, L. H., Prokaeva, T. B., Lim, A., Théberge, R., Falk, R. H., Doros, G. D., Berg, A. M., Costello, C. E., O’Hara, C., Seldin, D. C., et al. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.08.006 · Cited by 151
Conceição, I. M., & de Carvalho, M. A. (2006) · Muscle & Nerve · doi:10.1002/mus.20644 · Cited by 128
Hereditary transthyretin amyloidosis from a Scandinavian perspective
Suhr, O. B., Svendsen, I. H., Andersson, R., Danielsson, A., Holmgren, G., & Ranløv, P. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01173.x · Cited by 105
Bhuiyan, T., Helmke, S. T., Patel, A. R., Ruberg, F. L., Packman, J., Cheung, K. N., Grogan, D. R., & Maurer, M. S. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.910455 · Cited by 99
Buxbaum, J. N., Tagoe, C. E., Gallo, G., Walker, J. R., Kurian, S. M., & Salomon, D. R. (2012) · The FASEB Journal · doi:10.1096/fj.11-189571 · Cited by 85
Suhr, O. B., Lindqvist, P., Olofsson, B., Waldenström, A. P., & Backman, C. (2006) · Amyloid · doi:10.1080/13506120600876849 · Cited by 68
Esmaeilzadeh, M., Parsaee, M., Peighambari, M. M., Sadeghpour, A., Khamooshi, A. J., Hosseini, S., & Mozaffari, K. (2008) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ejechocard/jen204 · Cited by 65
Heart Transplantation for Homozygous Familial Transthyretin (TTR) V122I Cardiac Amyloidosis
Hamour, I. M., Lachmann, H. J., Goodman, H. J. B., Petrou, M., Burke, M. M., Hawkins, P. N., & Banner, N. R. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02162.x · Cited by 51
Almeida, M. R., Ferlini, A., Forabosco, A., GAWINOWICZ, M.-A., Costa, P. P., Salvi, F., Plasmati, R., Tassinari, C. A., Altland, K., & Saraiva, M. J. (1992) · Human Mutation · doi:10.1002/humu.1380010306 · Cited by 43
Self-citation
Cited by
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Self-citationGuideline of transthyretin-related hereditary amyloidosis for clinicians
Ando, Y., Coelho, T., Berk, J. L., Cruz, M. W., Ericzon, B.-G., Ikeda, S.-I., Lewis, W. D., Obici, L., Planté-Bordeneuve, V., Rapezzi, C., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-31 · Cited by 719
Self-citationGenotype and Phenotype of Transthyretin Cardiac Amyloidosis
Maurer, M. S., Hanna, M., Grogan, M., Dispenzieri, A., Witteles, R., Drachman, B., Judge, D. P., Lenihan, D. J., Gottlieb, S. S., Shah, S. J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.596 · Cited by 538
Self-citationAddressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis
Maurer, M. S., Elliott, P., Comenzo, R., Semigran, M., & Rapezzi, C. (2017) · Circulation · doi:10.1161/circulationaha.116.024438 · Cited by 492
Self-citationDiagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
Gertz, M. A., Benson, M. D., Dyck, P. J., Grogan, M., Coelho, T., Cruz, M., Berk, J. L., Plante-Bordeneuve, V., Schmidt, H. H. J., & Merlini, G. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.075 · Cited by 475
Self-citation
Metadata
- Authors
- Rapezzi, C., Quarta, C. C., Obici, L., Perfetto, F., Longhi, S., Salvi, F., Biagini, E., Lorenzini, M., Grigioni, F., Leone, O., Cappelli, F., Palladini, G., Rimessi, P., Ferlini, A., Arpesella, G., Pinna, A. D., Merlini, G., & Perlini, S.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-06-28
- Volume
- 34
- Issue
- 7
- Pages
- 520-528
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2096319356
- Cited by
- 332
- References
- 32
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.